Closed-loop neuromodulation in neuropsychiatric and neurological disorders.
www.frontiersin.org
Oct. 21, 2026, 1:17 p.m.
Closed-loop neuromodulation represents a significant advancement in treating neurological and neuropsychiatric disorders including Parkinson's disease, epilepsy, treatment-resistant depression, and obsessive-compulsive disorder. Unlike conventional open-loop systems that deliver stimulation on fixed schedules regardless of patient status, closed-loop approaches continuously monitor neural biomarkers such as local field potentials and oscillatory activity, then adjust stimulation parameters in real time based on the patient's fluctuating brain state and symptoms. This adaptive methodology enhances therapeutic efficacy while reducing side effects from inappropriate stimulation levels. Established devices like the NeuroPace RNS system for epilepsy and emerging adaptive deep brain stimulation platforms demonstrate clinical promise, though they raise critical questions regarding biomarker identification, algorithm design, device engineering, and ethical implications of continuous brain monitoring. A comprehensive research initiative seeks to consolidate current knowledge on closed-loop system design, validation, and clinical implementation across diverse conditions. Priority areas include neural biomarker validation, real-time feedback algorithms, clinical trial outcomes, comparative open-loop versus closed-loop studies, machine learning applications, hardware innovations in brain-computer interfaces, and regulatory and ethical considerations governing continuous neural monitoring and adaptive stimulation technologies.